Sabra Health Care REIT Inc expected to post earnings of 15 cents a share - Earnings Preview

Sabra Health Care REIT

06/08/2024 03:43

* Sabra Health Care REIT Inc  SBRA.OQ   SBRA.O  is expected
to show a rise in quarterly revenue when it reports  results on
August 7 for the period ending June 30 2024
    * The Irvine California-based  company is expected to report
a
3.0% increase in revenue to $166.032 million from $161.17
million a year ago, according to the mean estimate from 9
analysts, based on LSEG data. (SAL Represents Rental revenue/
Total revenue)
    * ​LSEG's mean analyst estimate for Sabra Health Care REIT
Inc is
for earnings of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sabra
Health Care
REIT Inc is $16.00​, below​ its last closing price of $16.02.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  0.33        0.33       0.34      Beat    2.7
 Dec. 31 2024  0.33        0.33       0.32      Missed  -3.2
 Sep. 30 2023  0.33        0.33       0.33      Met     -0.8​
 Jun. 30 2023  0.33        0.33       0.33      Met     -1.3
 ​​Mar.        0.34        0.34       0.33      Missed  -4
 31 2023                                                
 Dec. 31 2022  0.35        0.36       0.37      Beat    4.1​
 Sep. 30 2022  0.37        0.37       0.36      Missed  -3.2
 Jun. 30 2022  0.38        0.38       0.39      Beat    3.6
 This summary was machine generated August 6 at 02:43 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)